Abstract | BACKGROUND: PROCEDURE: RESULTS: The pain scores showed a significant difference between the two solutions of asparaginase (+/- lidocaine) (P value < 0.0001). Lidocaine did not influence the pharmacokinetics of the drug. CONCLUSIONS:
Asparaginase with addition of lidocaine significantly decreases the pain as measured by the visual analog scale without changing the bioavailability or the absorption rate of the enzyme.
|
Authors | Birgitte Klug Albertsen, Henrik Hasle, Niels Clausen, Henrik Schrøder, Preben Jakobsen |
Journal | Pediatric blood & cancer
(Pediatr Blood Cancer)
Vol. 44
Issue 3
Pg. 255-8
(Mar 2005)
ISSN: 1545-5009 [Print] United States |
PMID | 15503298
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | (c) 2004 Wiley-Liss, Inc. |
Chemical References |
- Anesthetics, Local
- Antineoplastic Agents
- Drug Combinations
- Lidocaine
- Asparaginase
|
Topics |
- Adolescent
- Anesthetics, Local
(administration & dosage)
- Antineoplastic Agents
(administration & dosage, pharmacokinetics)
- Asparaginase
(administration & dosage, pharmacokinetics)
- Biological Availability
- Child
- Child, Preschool
- Double-Blind Method
- Drug Combinations
- Humans
- Injections, Intramuscular
- Leukemia, Lymphoid
(drug therapy)
- Lidocaine
(administration & dosage)
- Pain
(drug therapy)
- Pain Measurement
|